Research and innovation into the development of novel therapeutics and ways of detecting diseases, as well as on how to improve the practice of pharmacy, is central to the activities of the School of Pharmacy and Biomolecular Sciences at RCSI.

Our staff conduct cutting-edge research on multiple disease areas of profound clinical importance, including cancers, neurodegenerative disorders, infectious diseases, haematological and immunological disorders, all with a view towards identifying novel therapeutic targets.

Our research impact

book 75 Publications in Q1 journals (global average: 46%)
lightbulb 21 Patents/invention disclosures
2.94 Field-weighted citation impact – three times the global average
50 Publications with international collaboration (global average: 21%)
Connect with us

Stay up-to-date with new research finding in the School of Pharmacy and Biomolecular Sciences by following us on Twitter.

Follow us on Twitter Follow us on Twitter